Congressional trading data flags unusual activity in stocks heading into earnings season. Dana Incorporated and Cochlear Limited stand out with combined trade counts of eight across sitting members, led by Rep. Michael McCaul in DAN and Rep. Ro Khanna in COH. The timing raises questions given the proximity to scheduled reports and recent analyst revisions for both names.
Dana Incorporated (NYSE: DAN) carries five disclosed trades linked to McCaul. The automotive supplier is expected to report Q2 2026 results around August 3-4 with consensus EPS estimates of $0.62 to $0.64 on roughly $1.93 billion in revenue. That follows a Q1 miss and comes against full-year adjusted EPS guidance in the $2.00-$3.00 range. Analyst price targets cluster between $30 and $38, implying double-digit upside if results meet lowered expectations. McCaul's activity adds to broader congressional interest in consumer cyclical names including TSLA, where Reps. Gilbert Cisneros and Khanna also filed trades.
Cochlear Limited faces its own pressures. Three trades tie back to Khanna ahead of the company's full-year FY2026 report expected between August 13-18. Analysts have revised EPS estimates downward to approximately AU$4.74 after the firm cut underlying net profit guidance to AU$290-330 million in April. Longer-term FY2027 forecasts sit near AU$5.18 with average price targets around AU$127. The healthcare name joins other politician favorites such as MU and AMGN also showing repeated filings from Khanna and peers including Reps. April McClain Delaney, Suzan DelBene, and Scott Peters.
The broader earnings watch list includes 27 additional trades across unspecified or varied tickers by lawmakers such as Reps. Steve Cohen, John Boozman, and Greg Steube. Energy name COP and industrial name BA also logged multiple disclosures. While the filings show mixed positioning with no clear net buys or sells dominating the data, the cluster of activity ahead of these catalysts suggests lawmakers may be bracing for sector-specific moves in consumer cyclical, technology, and healthcare. Market reactions to recent guidance cuts at COH and DAN's Q1 shortfall illustrate the volatility at stake.
This is data analysis, not financial advice.
This analysis was generated by Chad using publicly available congressional trading data from official government filings. This is not financial advice. All data is sourced from senate.gov, clerk.house.gov, and SEC EDGAR.